288 related articles for article (PubMed ID: 17079317)
1. Importance of receptor usage, Fli1 activation, and mouse strain for the stem cell specificity of 10A1 murine leukemia virus leukemogenicity.
Rodenburg M; Fischer M; Engelmann A; Harbers SO; Ziegler M; Löhler J; Stocking C
J Virol; 2007 Jan; 81(2):732-42. PubMed ID: 17079317
[TBL] [Abstract][Full Text] [Related]
2. 10A1 MuLV induces a murine leukemia that expresses hematopoietic stem cell markers by a mechanism that includes fli-1 integration.
Ott DE; Keller J; Rein A
Virology; 1994 Dec; 205(2):563-8. PubMed ID: 7975258
[TBL] [Abstract][Full Text] [Related]
3. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
4. Biological characterization and molecular cloning of murine C-type retroviruses derived from the TSZ complex from mainland China.
Bundy LM; Ru M; Zheng BF; Cheng L; Pattengale PK; Portis JL; Fan H
Virology; 1995 Oct; 212(2):367-82. PubMed ID: 7571406
[TBL] [Abstract][Full Text] [Related]
5. F-MuLV acceleration of myelomonocytic tumorigenesis in SV40 large T antigen transgenic mice is accompanied by retroviral insertion at Fli1 and a novel locus, Fim4.
Kone J; Arroyo J; Savinelli T; Lin S; Boyd K; Wu Y; Nimmakayalu M; Copeland NG; Jenkins NA; Qumsiyeh M; Hu P; Prescott A; Wu H; Yang L; Roe B; Perkins AS
Leukemia; 2002 Sep; 16(9):1827-34. PubMed ID: 12200699
[TBL] [Abstract][Full Text] [Related]
6. Phenotypes of murine leukemia virus-induced tumors: influence of 3' viral coding sequences.
Ott DE; Keller J; Sill K; Rein A
J Virol; 1992 Oct; 66(10):6107-16. PubMed ID: 1326661
[TBL] [Abstract][Full Text] [Related]
7. Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia.
Cui JW; Vecchiarelli-Federico LM; Li YJ; Wang GJ; Ben-David Y
Leukemia; 2009 Jul; 23(7):1311-9. PubMed ID: 19282832
[TBL] [Abstract][Full Text] [Related]
8. Analysis of wild-type and mutant SL3-3 murine leukemia virus insertions in the c-myc promoter during lymphomagenesis reveals target site hot spots, virus-dependent patterns, and frequent error-prone gap repair.
Nielsen AA; Sørensen AB; Schmidt J; Pedersen FS
J Virol; 2005 Jan; 79(1):67-78. PubMed ID: 15596802
[TBL] [Abstract][Full Text] [Related]
9. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
Green PL; Kaehler DA; McKearn J; Risser R
Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
[TBL] [Abstract][Full Text] [Related]
10. Identification of genetic determinants responsible for the rapid immunosuppressive activity and the low leukemogenic potential of a variant of Friend leukemia virus, FIS-2.
Dai HY; Troseth GI; Gunleksrud M; Bruland T; Solberg LA; Aarset H; Kristiansen LI; Dalen A
J Virol; 1998 Feb; 72(2):1244-51. PubMed ID: 9445024
[TBL] [Abstract][Full Text] [Related]
11. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
Wong KS; Li YJ; Howard J; Ben-David Y
Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
[TBL] [Abstract][Full Text] [Related]
12. Expression of infectious murine leukemia viruses by RAW264.7 cells, a potential complication for studies with a widely used mouse macrophage cell line.
Hartley JW; Evans LH; Green KY; Naghashfar Z; Macias AR; Zerfas PM; Ward JM
Retrovirology; 2008 Jan; 5():1. PubMed ID: 18177500
[TBL] [Abstract][Full Text] [Related]
13. Recombinant mink cell focus-inducing virus and long terminal repeat alterations accompany the increased leukemogenicity of the Mo+PyF101 variant of Moloney murine leukemia virus after intraperitoneal inoculation.
Belli B; Patel A; Fan H
J Virol; 1995 Feb; 69(2):1037-43. PubMed ID: 7815481
[TBL] [Abstract][Full Text] [Related]
14. Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies.
Largaespada DA
Leukemia; 2000 Jul; 14(7):1174-84. PubMed ID: 10914539
[TBL] [Abstract][Full Text] [Related]
15. Enhancer mutations of Akv murine leukemia virus inhibit the induction of mature B-cell lymphomas and shift disease specificity towards the more differentiated plasma cell stage.
Sørensen KD; Kunder S; Quintanilla-Martinez L; Sørensen J; Schmidt J; Pedersen FS
Virology; 2007 May; 362(1):179-91. PubMed ID: 17258785
[TBL] [Abstract][Full Text] [Related]
16. Insertional activation of myb by F-MuLV in SCID mice induces myeloid leukemia.
Haeri M; Li Y; Li Y; Li Q; Spaner DE; Ben-David Y
Int J Oncol; 2013 Jul; 43(1):169-76. PubMed ID: 23677281
[TBL] [Abstract][Full Text] [Related]
17. Mus cervicolor murine leukemia virus isolate M813 belongs to a unique receptor interference group.
Prassolov V; Hein S; Ziegler M; Ivanov D; Münk C; Löhler J; Stocking C
J Virol; 2001 May; 75(10):4490-8. PubMed ID: 11312319
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
Nazarov V; Hilbert D; Wolff L
Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
[TBL] [Abstract][Full Text] [Related]
19. Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.
Johnson C; Lobelle-Rich PA; Puetter A; Levy LS
J Virol; 2005 Jan; 79(1):57-66. PubMed ID: 15596801
[TBL] [Abstract][Full Text] [Related]
20. Generation and pathogenicity of an NB-tropic SL3-3 murine leukemia virus.
Thomas CY; Nuckols JD; Murphy C; Innes D
Virology; 1993 Apr; 193(2):1013-7. PubMed ID: 8384741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
